tiprankstipranks
Advertisement
Advertisement
Alzamend Neuro’s AL001 shows “encouraging” data in Phase II brain trial
PremiumThe FlyAlzamend Neuro’s AL001 shows “encouraging” data in Phase II brain trial
4M ago
Alzamend Neuro reports ‘positive’ data from Phase II clinical trial of AL001
Premium
The Fly
Alzamend Neuro reports ‘positive’ data from Phase II clinical trial of AL001
5M ago
Alzamend Neuro Receives Nasdaq Notice Over Equity Deficiency
Premium
Company Announcements
Alzamend Neuro Receives Nasdaq Notice Over Equity Deficiency
5M ago
Alzamend Neuro Issues New Common Stock Shares
PremiumCompany AnnouncementsAlzamend Neuro Issues New Common Stock Shares
10M ago
Alzamend Neuro Boosts Liquidity with Stock Issuance
Premium
Company Announcements
Alzamend Neuro Boosts Liquidity with Stock Issuance
11M ago
Alzamend Neuro Increases Common Stock Through Conversion
Premium
Company Announcements
Alzamend Neuro Increases Common Stock Through Conversion
1y ago
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
PremiumMarket NewsMorning News Wrap-Up: Thursday’s Biggest Stock Market Stories
1y ago
Alzamend Neuro doses first patient in Phase II study of AL001
Premium
The Fly
Alzamend Neuro doses first patient in Phase II study of AL001
1y ago
Alzamend Neuro enrolls first patient in Phase II trial of AL001
Premium
The Fly
Alzamend Neuro enrolls first patient in Phase II trial of AL001
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100